Maxillary full-arch rehabilitation using the new NobelZygoma™ TiUltra™ implants
Prof. Enrico Agliardi
Italy
"The NobelZygoma TiUltra 0° is a great leap forward from the previous generation of zygomatic implants. The small diameter and conical connection offer advantages both surgically and prosthetically. Furthermore, the TiUltra surface ensures minimal tissue trauma making them more stable over time. In addition to all this, the new drill system offers optimal implant site preparation in every anatomical situation and greatly simplifies every single step. The entire system for treating patients with severe maxillary atrophy using zygomatic implants now has a new gold-standard thanks to Nobel Biocare."
Patient: A 72-year-old female with no systemic conditions and a history of failing implants and grafts in the left upper side.
Clinical situation: The patient presents failing residual teeth in the upper jaw and a failing implant in region 23. She has recurrent sinusitis due to an oral antral communication in region 24-25.
Proposed surgical solution: Extraction of the remaining maxillary teeth with immediate implant placement, consisting of two anterior NobelSpeedy® Groovy implants, one tilted NobelSpeedy® Groovy in region 13 of dimension 4mm and a 37.5mm NobelZygoma 0° TiUltra implants in region 25. The plan includes immediate loading with a pre-fabricated provisional PMMA prosthesis.
Temporization: Immediate loading of the implants with a PMMA provisional prosthesis, secured on temporary Mult-unit Abutments during the initial healing phase.
Surgery date: September 18, 2024
Total treatment time: 6 months including the definitive prosthesis. The provisional prosthesis was delivered the same day of the surgery.
-
NobelZygoma
Immediate, graftless, fixed solutions for patients with severe maxillary atrophy.
-
Multi-unit Abutment
Key to the original All-on-4® treatment concept.
Sign up for our blog update
Get the latest clinical cases, industry news, product information and more.
© Nobel Biocare Services AG, 2024. All rights reserved. Distributed by: Nobel Biocare. Nobel Biocare, the Nobel Biocare logotype and all other trademarks are, if nothing else is stated or is evident from the context in a certain case, trademarks of Nobel Biocare. Please refer to nobelbiocare.com/trademarks for more information. Product images are not necessarily to scale. All product images are for illustration purposes only and may not be an exact representation of the product. Please contact the local Nobel Biocare sales office for current product assortment and availability. Disclaimer: For prescription use only. Caution: Federal (United States) law or the law in your jurisdiction may restrict this device to sale by or on the order of a licensed clinician, medical professional or physician. See Instructions For Use for full prescribing information, including indications, contraindications, warnings and precautions. Nobel Biocare does not take any liability for any injury or damage to any person or property arising from the use of this clinical case. This clinical case is not intended to recommend any measures, techniques, procedures or products, or give advice, and is not a substitute for medical training or your own clinical judgement as a healthcare professional. Viewers should never disregard professional medical advice or delay seeking medical treatment because of something they have seen in this clinical case.Full procedure is not shown. Certain sequences have been cut. Please refer to applicable IFUs for full instruction. Prof. Agliardi is a paid consultant for Nobel Biocare. The opinions expressed are those of the doctor. Nobel Biocare is a medical device manufacturer and does not dispense medical advice. Clinicians should use their own professional judgment in treating their patients. Individual patient results may vary.